Blood substitutes: why haven't we been more successful?: Trends in Biotechnology
![PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9a9dab9236a3f7d9bf7551281a0be034d8fdc6b/5-Table1-1.png "PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar")
PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar
A Chemoenzymatic Approach to the Synthesis of Hemoglobin Oligomers | Semantic Scholar
Artificial blood
Biomolecules | Free Full-Text | Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help? | HTML
Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. - Abstract - Europe PMC
PPT - Hemoglobin-Based Oxygen Carriers: An Update PowerPoint Presentation - ID:9284426
How Artificial Blood Works | HowStuffWorks
Adjusted cEPI means were compared in two treatment groups, HBOC-201 and... | Download Scientific Diagram
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study
Hemoglobin-based Oxygen Carriers: First, Second or Third Generation? Human or Bovine? Where are we Now? - Critical Care Clinics
Targeted Oxygen Delivery within Hepatic Hollow Fiber Bioreactors via Supplementation of Hemoglobin‐Based Oxygen Carriers - Sullivan - 2006 - Biotechnology Progress - Wiley Online Library
Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes: Trends in Biotechnology
![PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9a9dab9236a3f7d9bf7551281a0be034d8fdc6b/7-Figure1-1.png "PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar")
PDF] A phase I single blind clinical trial of a new oxygen transport agent ( MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. | Semantic Scholar
HBOCs from Chemical Modification of Hb | SpringerLink
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study
HBOC products as Blood Substitute. | Download Scientific Diagram
Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. - Abstract - Europe PMC
EX-99.1 2 ea119536ex99-1_bioxytran.htm BIOXYTRAN, INC. PRESENTATION, DATED MARCH 12, 2020 Exhibit
Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study - Journal of Cardiothoracic and Vascular Anesthesia
Inhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension | Circulation
Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model - ScienceDirect
Current Status and Future of Artificial Blood - Focusing on Red Blood Cell Substitutes
Hemoglobin-Based Oxygen Carriers: An Update - ppt download
Does OxyVita, a New-Generation Hemoglobin-Based Oxygen Carrier, or Oxyglobin Acutely Interfere With Coagulation Compared With Normal Saline or 6% Hetastarch? An Ex Vivo Thromboelastography Study - Journal of Cardiothoracic and Vascular Anesthesia
